Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 318

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Heart Failure in COVID-19 Patients: Prevalence, Incidence and Prognostic Implications

Open access
Rey, Juan R., Caro-Codón, Juan, Rosillo, Sandra O., Iniesta, Ángel M., Castrejón-Castrejón, Sergio, Marco-Clement, Irene, Martín-Polo, Lorena, Merino-Argos, Carlos, Rodríguez-Sotelo, Laura, García-Veas, Jose M., Martínez-Marín, Luis A., Martínez-Cossiani, Marcel, Buño, Antonio, Gonzalez-Valle, Luis, Herrero, Alicia, López-Sendón, José L., Merino, José L., for the CARD-COVID Investigators·2020·European Journal of Heart Failure

Abstract

Aims: Data on the impact of COVID-19 in chronic heart failure (CHF) patients and its potential to trigger acute heart failure (AHF) are lacking. The aim of this work was to study characteristics, cardiovascular outcomes and mortality in patients with confirmed COVID-19 infection and a prior diagnosis of heart failure (HF). Further aims included the identification of predictors and prognostic implications for AHF decompensation during hospital admission and the determination of a potential correlation between the withdrawal of HF guideline-directed medical therapy (GDMT) and worse outcomes during hospitalization. Methods and results: Data for a total of 3080 consecutive patients with confirmed COVID-19 infection and follow-up of at least 30 days were analysed. Patients with a previous history of CHF (n = 152, 4.9%) were more prone to the development of AHF (11.2% vs. 2.1%; P < 0.001) and had higher levels of N-terminal pro brain natriuretic peptide. In addition, patients with previous CHF had higher mortality rates (48.7% vs. 19.0%; P < 0.001). In contrast, 77 patients (2.5%) were diagnosed with AHF, which in the vast majority of cases (77.9%) developed in patients without a history of HF. Arrhythmias during hospital admission and CHF were the main predictors of AHF. Patients developing AHF had significantly higher mortality (46.8% vs. 19.7%; P < 0.001). Finally, the withdrawal of beta-blockers, mineralocorticoid receptor antagonists and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers was associated with a significant increase in in-hospital mortality. Conclusions: Patients with COVID-19 have a significant incidence of AHF, which is associated with very high mortality rates. Moreover, patients with a history of CHF are prone to developing acute decompensation after a COVID-19 diagnosis. The withdrawal of GDMT was associated with higher mortality.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ejhf.1990

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 318

Metadata

Authors
Rey, J. R., Caro-Codón, J., Rosillo, S. O., Iniesta, Á. M., Castrejón-Castrejón, S., Marco-Clement, I., Martín-Polo, L., Merino-Argos, C., Rodríguez-Sotelo, L., García-Veas, J. M., Martínez-Marín, L. A., Martínez-Cossiani, M., Buño, A., Gonzalez-Valle, L., Herrero, A., López-Sendón, J. L., Merino, J. L., & for the CARD-COVID Investigators
Venue
European Journal of Heart Failure
Published
2020-10-07
Volume
22
Issue
12
Pages
2205-2215
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W3080657276
Cited by
318
References
31
FWCI
35.75
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Heart Failure in COVID-19 Patients: Prevalence, Incidence and Prognostic Implications. https://app.cochat.ai/papers/10.1002/ejhf.1990
The paper
Rey, J. R., Caro-Codón, J., Rosillo, S. O., Iniesta, Á. M., Castrejón-Castrejón, S., Marco-Clement, I., Martín-Polo, L., Merino-Argos, C., Rodríguez-Sotelo, L., García-Veas, J. M., Martínez-Marín, L. A., Martínez-Cossiani, M., Buño, A., Gonzalez-Valle, L., Herrero, A., López-Sendón, J. L., Merino, J. L., & for the CARD-COVID Investigators. (2020). Heart Failure in COVID-19 Patients: Prevalence, Incidence and Prognostic Implications. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.1990

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.